Shuttle Pharmaceuticals Holdings (SHPH) Cash from Operations (2021 - 2026)
Shuttle Pharmaceuticals Holdings (SHPH) posted quarterly Cash from Operations of 2417309.0 for Q1 2026, up 4.34% year-over-year from 2316808.56 in Q1 2025, and down 148.44% quarter-over-quarter from 973012.0 in Q4 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Cash from Operations (2021 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Cash from Operations history runs 6 years deep, the most recent figure standing at 2417309.0 for Q1 2026.
- In Q1 2026, Cash from Operations rose 4.34% year-over-year to 2417309.0; the TTM figure through Mar 2026 stood at 9372030.0 (down 8.79% YoY), while the FY2025 annual figure was 9481645.0, down 29.4% from the prior year.
- Cash from Operations for Q1 2026 stood at 2417309.0, down from 973012.0 in the prior quarter.
- The five-year high for Cash from Operations was 355420.0 in Q2 2022, with the low at 3355055.0 in Q2 2025.
- The 5-year median for Cash from Operations is 1399342.0 (2024), against an average of 1616102.47.
- The sharpest annual moves came in 2022 and 2025: Cash from Operations tumbled 370.45% in 2022, then surged 63.83% in 2025.
- Shuttle Pharmaceuticals Holdings' Cash from Operations stood at 635824.0 in 2022, then tumbled by 67.05% to 1062174.0 in 2023, then slumped by 153.27% to 2690162.0 in 2024, then soared by 63.83% to 973012.0 in 2025, then tumbled by 148.44% to 2417309.0 in 2026.
- Business Quant data shows SHPH's Cash from Operations at 2417309.0 in Q1 2026, 973012.0 in Q4 2025, and 2626654.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Shuttle Pharmaceuticals Holdings | 1.87 Mn | 1.87 Mn | - | -2.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.42 Mn |
| Mar 31, 2026 | -2.42 Mn |
| Dec 31, 2025 | -973,012.00 |
| Dec 31, 2025 | -973,012.00 |
| Sep 30, 2025 | -2.63 Mn |
| Sep 30, 2025 | -2.63 Mn |
| Jun 30, 2025 | -3.36 Mn |
| Jun 30, 2025 | -3.36 Mn |
| Mar 31, 2025 | -2.53 Mn |
| Mar 31, 2025 | -2.53 Mn |
| Dec 31, 2024 | -2.69 Mn |
| Dec 31, 2024 | -2.69 Mn |
| Sep 30, 2024 | -2.00 Mn |
| Sep 30, 2024 | -2.00 Mn |
| Jun 30, 2024 | -1.40 Mn |
| Jun 30, 2024 | -1.40 Mn |
| Mar 31, 2024 | -1.24 Mn |
| Mar 31, 2024 | -1.24 Mn |
| Dec 31, 2023 | -1.06 Mn |
| Dec 31, 2023 | -1.06 Mn |